ARK Genomic Revolution ETF vs Intel Corp — how do they compare? ARK Genomic Revolution ETF trades at $44.49, while Intel Corp trades at $99.06 (market cap $492.85B). The key difference: Intel Corp pays a 2.24% dividend while ARK Genomic Revolution ETF pays none, and ARK Genomic Revolution ETF is trading nearer its 52-week high, Intel Corp nearer its low. Which is the better fit depends on your goals.
| ARKG | INTC | |
|---|---|---|
Sector | Sector/Thematic | Technology |
52-Week High | $44.55 | $140.94 |
52-Week Low | $24.02 | $21.81 |
Market Cap | — | $492.85B |
Volume | — | 43,552,012 |
Enterprise Value | — | $513.66B |
Dividend Yield | — | 2.24% |
Trailing returns across standard periods
Latest headlines on both assets
ARKG is an actively managed ETF that invests in the genomic revolution. It focuses on companies leading in gene editing, CRISPR technology, therapeutics, and molecular diagnostics, including firms like CRISPR Therapeutics and Tempus AI.
Read more on ARKG →Intel Corporation designs, manufactures, and sells computer components and related products. The Company major products include microprocessors, chipsets, embedded processors and microcontrollers, flash memory, graphic, network and communication, systems management software, conferencing, and digital imaging products.
Read more on INTC →